GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AXIM Biotechnologies Inc (OTCPK:AXIM) » Definitions » Shiller PE Ratio

AXIM Biotechnologies (AXIM Biotechnologies) Shiller PE Ratio : (As of May. 02, 2024)


View and export this data going back to 2013. Start your Free Trial

What is AXIM Biotechnologies Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


AXIM Biotechnologies Shiller PE Ratio Historical Data

The historical data trend for AXIM Biotechnologies's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AXIM Biotechnologies Shiller PE Ratio Chart

AXIM Biotechnologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

AXIM Biotechnologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of AXIM Biotechnologies's Shiller PE Ratio

For the Biotechnology subindustry, AXIM Biotechnologies's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AXIM Biotechnologies's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AXIM Biotechnologies's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where AXIM Biotechnologies's Shiller PE Ratio falls into.



AXIM Biotechnologies Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

AXIM Biotechnologies's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, AXIM Biotechnologies's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.013/129.4194*129.4194
=-0.013

Current CPI (Dec. 2023) = 129.4194.

AXIM Biotechnologies Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.000 99.695 0.000
201406 -0.001 100.560 -0.001
201409 -0.004 100.428 -0.005
201412 -0.010 99.070 -0.013
201503 -0.020 99.621 -0.026
201506 -0.040 100.684 -0.051
201509 -0.040 100.392 -0.052
201512 -0.170 99.792 -0.220
201603 -0.020 100.470 -0.026
201606 -0.050 101.688 -0.064
201609 -0.070 101.861 -0.089
201612 -0.020 101.863 -0.025
201703 -0.010 102.862 -0.013
201706 -0.010 103.349 -0.013
201709 -0.030 104.136 -0.037
201712 -0.030 104.011 -0.037
201803 -0.050 105.290 -0.061
201806 -0.030 106.317 -0.037
201809 -0.020 106.507 -0.024
201812 -0.020 105.998 -0.024
201903 -0.040 107.251 -0.048
201906 -0.030 108.070 -0.036
201909 -0.010 108.329 -0.012
201912 -0.020 108.420 -0.024
202003 -0.030 108.902 -0.036
202006 0.000 108.767 0.000
202009 -0.020 109.815 -0.024
202012 -0.020 109.897 -0.024
202103 -0.010 111.754 -0.012
202106 -0.030 114.631 -0.034
202109 -0.030 115.734 -0.034
202112 -0.060 117.630 -0.066
202203 -0.010 121.301 -0.011
202206 -0.010 125.017 -0.010
202209 -0.012 125.227 -0.012
202212 -0.006 125.222 -0.006
202303 -0.010 127.348 -0.010
202306 -0.020 128.729 -0.020
202309 0.001 129.860 0.001
202312 -0.013 129.419 -0.013

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


AXIM Biotechnologies  (OTCPK:AXIM) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


AXIM Biotechnologies Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of AXIM Biotechnologies's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AXIM Biotechnologies (AXIM Biotechnologies) Business Description

Traded in Other Exchanges
N/A
Address
6191 Cornerstone Court, E, Suite 114, San Diego, CA, USA, 92121
Axim Biotechnologies Inc is a vertically integrated research and development company focused on improving the landscape for the diagnosis of ophthalmological conditions such as Dry Eye Disease through rapid diagnostic tests. Additionally, it owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid neutralizing antibody tests to detect levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells, as well as for oncological indications.
Executives
Kurt Phinney officer: Chief Operating Officer 6914 MAGELLAN WAY, SARASOTA FL 34243
Peter O'rourke director C/O NORTHVIEW ACQUISITION CORP., 207 WEST 25TH STREET, 9TH FLOOR, NEW YORK NY 10001
Catalina Valencia 10 percent owner 6191 CORNERSTONE COURT, E, SUITE 114, SAN DIEGO CA 92121
Glycodots, Llc 10 percent owner 6191 CORNERSTONE COURT, E, SUITE 114, SAN DIEGO CA 92121
Juniper & Ivy Corp 10 percent owner 5201 MEMORIAL DRIVE, SUITE 616, HOUSTON TX 77007
Huemoeller John Walter Ii director 305 SAN ANSELMO AVENUE, SUITE 300, SAN ANSELMO CA 94960
Blake Schroeder director 5 ROCKERFELLER PLACE, 20TH FLOOR, SUITE 83, NEW YORK NY 10111
Robert L Cunningham director 5 ROCKERFELLER PLACE, 20TH FLOOR, SUITE 83, NEW YORK NY 10111
Timothy Richard Scott director 5 ROCKERFELLER PLACE, 20TH FLOOR, SUITE 83, NEW YORK NY 10111
Robert Malasek officer: CFO PO BOX 235472, ENCINITAS CA 92023
Lekhram Changoer 10 percent owner 18 EAST 50TH STREET, 5TH FLOOR, NEW YORK NY 10022
Medical Marijuana, Inc. 10 percent owner 12255 CROSTHWAITE CIRCLE, POWAY CA 92064
Van Damme Philip A 10 percent owner 18 EAST 50TH STREET, 5TH FLOOR, NEW YORK NY 10022
Foundation Sanammad 10 percent owner 18 EAST 50TH STREET, 5TH FLOOR, NEW YORK NY 10022
George Anastassov 10 percent owner 18 EAST 50TH STREET, 5TH FLOOR, NEW YORK NY 10022

AXIM Biotechnologies (AXIM Biotechnologies) Headlines

From GuruFocus